Annual Shareholders Equity
$114.29 M
+$102.21 M+846.08%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual stockholders equity is $114.29 million, with the most recent change of +$102.21 million (+846.08%) on March 31, 2024.
- During the last 3 years, VTGN annual shareholders equity has risen by +$22.31 million (+24.25%).
- VTGN annual shareholders equity is now at all-time high.
Performance
VTGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$92.97 M
-$11.83 M-11.29%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly stockholders equity is $92.97 million, with the most recent change of -$11.83 million (-11.29%) on September 30, 2024.
- Over the past year, VTGN quarterly shareholders equity has stayed the same.
- VTGN quarterly shareholders equity is now -24.59% below its all-time high of $123.28 million, reached on December 31, 2023.
Performance
VTGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VTGN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +846.1% | 0.0% |
| 3 y3 years | +24.3% | 0.0% |
| 5 y5 years | +1515.3% | 0.0% |
VTGN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +846.1% | -24.6% | +1257.5% |
| 5 y | 5-year | at high | +2094.7% | -24.6% | +1625.5% |
| alltime | all time | at high | +656.3% | -24.6% | +552.6% |
VistaGen Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $92.97 M(-11.3%) |
| Jun 2024 | - | $104.80 M(-8.3%) |
| Mar 2024 | $114.29 M(+846.1%) | $114.29 M(-7.3%) |
| Dec 2023 | - | $123.28 M(+245.9%) |
| Sep 2023 | - | $35.65 M(+420.4%) |
| Jun 2023 | - | $6.85 M(-43.3%) |
| Mar 2023 | $12.08 M(-81.3%) | $12.08 M(-41.6%) |
| Dec 2022 | - | $20.67 M(-30.2%) |
| Sep 2022 | - | $29.61 M(-35.7%) |
| Jun 2022 | - | $46.05 M(-28.8%) |
| Mar 2022 | $64.72 M(-29.6%) | $64.72 M(-19.1%) |
| Dec 2021 | - | $79.98 M(-0.8%) |
| Sep 2021 | - | $80.66 M(-5.8%) |
| Jun 2021 | - | $85.62 M(-6.9%) |
| Mar 2021 | $91.98 M(-1705.4%) | $91.98 M(-2.0%) |
| Dec 2020 | - | $93.81 M(+2121.6%) |
| Sep 2020 | - | $4.22 M(-175.2%) |
| Jun 2020 | - | -$5.61 M(-2.1%) |
| Mar 2020 | -$5.73 M(-181.0%) | -$5.73 M(-6.0%) |
| Dec 2019 | - | -$6.09 M(+67.9%) |
| Sep 2019 | - | -$3.63 M(-323.3%) |
| Jun 2019 | - | $1.63 M(-77.0%) |
| Mar 2019 | $7.08 M(+2.3%) | $7.08 M(+318.0%) |
| Dec 2018 | - | $1.69 M(-57.6%) |
| Sep 2018 | - | $3.99 M(+23.8%) |
| Jun 2018 | - | $3.22 M(-53.4%) |
| Mar 2018 | $6.92 M(+1023.2%) | $6.92 M(-32.6%) |
| Dec 2017 | - | $10.26 M(-714.0%) |
| Sep 2017 | - | -$1.67 M(+175.5%) |
| Jun 2017 | - | -$606.80 K(-198.5%) |
| Mar 2017 | $615.80 K | $615.80 K(-76.2%) |
| Dec 2016 | - | $2.59 M(-36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $4.09 M(-33.7%) |
| Jun 2016 | - | $6.16 M(-307.0%) |
| Mar 2016 | -$2.98 M(-85.5%) | -$2.98 M(+86.3%) |
| Dec 2015 | - | -$1.60 M(+20.6%) |
| Sep 2015 | - | -$1.32 M(-53.8%) |
| Jun 2015 | - | -$2.87 M(-86.0%) |
| Mar 2015 | -$20.54 M(+60.5%) | -$20.54 M(+15.5%) |
| Dec 2014 | - | -$17.78 M(+2.4%) |
| Sep 2014 | - | -$17.37 M(+12.9%) |
| Jun 2014 | - | -$15.39 M(+20.2%) |
| Mar 2014 | -$12.80 M(+1.9%) | -$12.80 M(+9.7%) |
| Dec 2013 | - | -$11.67 M(-8.5%) |
| Sep 2013 | - | -$12.75 M(+6.7%) |
| Jun 2013 | - | -$11.95 M(-4.8%) |
| Mar 2013 | -$12.56 M(+120.1%) | -$12.56 M(+19.3%) |
| Dec 2012 | - | -$10.52 M(+62.9%) |
| Sep 2012 | - | -$6.46 M(+2.8%) |
| Jun 2012 | - | -$6.28 M(+10.1%) |
| Mar 2012 | -$5.71 M(>+9900.0%) | -$5.71 M(+19.8%) |
| Dec 2011 | - | -$4.76 M(-45.4%) |
| Sep 2011 | - | -$8.72 M(+23.5%) |
| Jun 2011 | - | -$7.07 M(>+9900.0%) |
| Mar 2011 | - | -$300.00(-70.0%) |
| Dec 2010 | -$1000.00(+900.0%) | -$1000.00(+42.9%) |
| Sep 2010 | - | -$700.00(-170.0%) |
| Jun 2010 | - | $1000.00(+900.0%) |
| Mar 2010 | - | $100.00(-200.0%) |
| Dec 2009 | -$100.00(-100.5%) | -$100.00(-107.7%) |
| Sep 2009 | - | $1300.00(+18.2%) |
| Jun 2009 | - | $1100.00(-94.6%) |
| Dec 2008 | $20.40 K | $20.40 K(-682.9%) |
| Jun 2008 | - | -$3500.00(+45.8%) |
| Mar 2008 | - | -$2400.00 |
FAQ
- What is VistaGen Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual shareholders equity year-on-year change?
- What is VistaGen Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly shareholders equity year-on-year change?
What is VistaGen Therapeutics annual stockholders equity?
The current annual shareholders equity of VTGN is $114.29 M
What is the all time high annual shareholders equity for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual stockholders equity is $114.29 M
What is VistaGen Therapeutics annual shareholders equity year-on-year change?
Over the past year, VTGN annual stockholders equity has changed by +$102.21 M (+846.08%)
What is VistaGen Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VTGN is $92.97 M
What is the all time high quarterly shareholders equity for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly stockholders equity is $123.28 M
What is VistaGen Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VTGN quarterly stockholders equity has changed by $0.00 (0.00%)